[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@dose_of_naz Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1244166951045402625.png) @dose_of_naz Dr. Nazifa Kadery, PharmD, RPh

Dr. Nazifa Kadery, PharmD, RPh posts on X about $4523t, $620m, csf, regeneron the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.

### Engagements: XX [#](/creator/twitter::1244166951045402625/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1244166951045402625/c:line/m:interactions.svg)

- X Week XXX +20%
- X Month XXXXX +493%
- X Months XXXXX +127%
- X Year XXXXXX +224%

### Mentions: X [#](/creator/twitter::1244166951045402625/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1244166951045402625/c:line/m:posts_active.svg)

- X Week XX -XX%
- X Month XX +400%
- X Months XXX +137%
- X Year XXX +246%

### Followers: XXX [#](/creator/twitter::1244166951045402625/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1244166951045402625/c:line/m:followers.svg)

- X Week XXX -XXXX%
- X Month XXX +5.40%
- X Months XXX +33%
- X Year XXX +59%

### CreatorRank: undefined [#](/creator/twitter::1244166951045402625/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1244166951045402625/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  XXXXX%

**Social topic influence**
[$4523t](/topic/$4523t) #17, [$620m](/topic/$620m) 5.56%, [csf](/topic/csf) 5.56%, [regeneron](/topic/regeneron) 5.56%, [mbc](/topic/mbc) XXXX%

**Top accounts mentioned or mentioned by**
[@gilead](/creator/undefined)
### Top Social Posts
Top posts by engagements in the last XX hours

"#Eisai Presents New Data on Anti-Tau Antibody #Etalanetug (E2814) at #CTAD2025 #MedTwitter #Alzheimers #Neurology"  
[X Link](https://x.com/dose_of_naz/status/1996237135649661298)  2025-12-03T15:16Z XXX followers, XXX engagements


"#Kites next-gen bicistronic CAR T-Cell tx show encouraging Ph1 results in r/r B-Cell #Lymphoma in new data at #ASH2025 #MedTwitter #Hematology #Oncology"  
[X Link](https://x.com/dose_of_naz/status/1997718248411033886)  2025-12-07T17:22Z XXX followers, XX engagements


"Mirum Pharma pays $620M to buy Bluejay Tx & its Ph3 #hepatitis drug #brelovitug (IgG1 #mAb that targets the surface antigen on both #HDV & #HBV) #MedTwitter #InfectiousDisease"  
[X Link](https://x.com/dose_of_naz/status/1998205021016703342)  2025-12-09T01:36Z XXX followers, XX engagements


"New Ph3: A Research Study on How Well #Cagrilintide and #CagriSema Work in #Children and #Adolescents With Excess Body Weight #MedTwitter #Cardiometabolic #NovoNordisk #ClinicalTrial #GLP1 #Obesity #WeightLoss"  
[X Link](https://x.com/dose_of_naz/status/1996230004670165026)  2025-12-03T14:48Z XXX followers, XX engagements


"New Data Presented at #CTAD2025 Confirms Pharmacological Effect of #LEQEMBI (#lecanemab-irmb) on Neurotoxic A Protofibrils in #CSF #Eisai #Biogen #MedTwitter #Neurology #Neurodegeneration"  
[X Link](https://x.com/dose_of_naz/status/1996234945837076989)  2025-12-03T15:07Z XXX followers, XXX engagements


"#ASH25: #Regeneron eyes simpler regimens in bid to move #bispecifics into earlier #bloodcancer tx #MedTwitter #Hematology #Oncology #DLBCL"  
[X Link](https://x.com/dose_of_naz/status/1998206494597361961)  2025-12-09T01:42Z XXX followers, XX engagements


"Ph3 HER2CLIMB-05: Adding #TUKYSA to 1L maintenance tx (trastuzumab + pertuzumab) in #HER2+ #mBC reduces the risk of disease progression or death by XX% vs. PCB (trastuzumab + pertuzumab) #SABCS25 #MedTwitter #Oncology #Pfizer #BreastCancer #TKI"  
[X Link](https://x.com/dose_of_naz/status/1998912945972195441)  2025-12-11T00:29Z XXX followers, XX engagements